The Path to the
True North.
Your next decision has an unpriced risk in it.
NAVETRA names where execution risk is concentrating and prices it — a board-grade dollar figure that doesn’t exist anywhere else in your stack, before the decision, not after the loss.
“I need to defend the people mandate to the CFO with a structured read of where the leadership team is actually pulling — not a feeling and not last year’s engagement score.”
“I need to sit with the COO and structurally decide which AI this company can actually hold — and which ones we should not buy at all this fiscal year.”
“I’m signing off on the next capex envelope, and I don’t actually know if we’re resourced to deliver it. The hurdle rate assumes execution. We’ve never priced that.”
“I need to walk into the audit committee with a dollar exposure on execution risk — not a heat map, not a KRI report, not another internal audit that catalogues findings but never prices them.”
One brief. One page. Before the decision.
The board-grade execution-risk read your ERM framework has a slot for — and no instrument to produce.
Quantified exposure of operating profit to execution friction this quarter. A sector-validated range.
Against this quarter’s operating profit. Your range lands on scan completion.
Where the exposure concentrates — the three execution domains carrying the most weight this quarter.
The diagnostic questions the committee should be working through this quarter.
That prices the environment in which your decisions land.
Your ERP, your risk register, your ERM framework — none of them produce a board-grade dollar figure on execution risk. NAVETRA runs one structured executive diagnostic and returns it — before the decision, not after the loss.
A structured executive diagnostic across your leadership team — the read your ERM framework has a slot for but no instrument to produce.
A sector-validated range, expressed as Operating Profit at Risk across ten execution domains. The method applies established, peer-reviewed research principles, calibrated through field experience across sectors. Patent-pending.
A brief that sits inside the ERM cadence your audit committee already runs — refreshed every quarter, before the next capital decision.
Twenty-three boards. The signal was already on the table.
All cases are governance failures, mapped after the fact. Every one of these had the data; none of them had it priced.
346 lives. 32 whistleblower complaints in the record. The leadership read drifted from the operator read for three years.
Profitable the year before it filed. The equipment-risk data was held and reported — carried as a maintenance backlog, never priced against the capital plan. Then Chapter 11.
An independent monitor documented the cost and schedule slip every cycle. Continued anyway, roughly seven years late. The continue decision was never priced.
Independent analysis of public information, applying the NAVETRA execution-governance framework for illustrative purposes. Not affiliated with, endorsed by, or reviewed by any company named. Figures are drawn from public reporting and cited on each case page.
The path to the true north of your company.
Start with the Free Risk Scan. The board-grade execution-risk number that doesn’t exist anywhere else in your stack — your top contributing domains, your first alignment items, your OPaR range, before the next decision, not after. No cost, no obligation.